Molina Healthcare, Inc.
MOH NYSEHealthcare ★★★★★Latest Earnings
Date
Jul 22, 2026
ET
EPS Est.
1.39
EPS Actual
1.51
Revenue Est.
$10.83B
Revenue Actual
$10.87B
Next Earnings Report
Date
Oct 28, 2026 · Wed
Time
After-market
Fiscal Period
FY2026 Q3
EPS Est.
0.82
Revenue Est.
$10.86B
Company Overview
Molina Healthcare, Inc. (ticker MOH) is listed on NYSE with a market cap of about $10.46B. Its next earnings report (FY2026 Q3) is expected on Oct 28, 2026 (ET), After-market, with consensus EPS of 0.82. In the last 15 reported quarters, EPS beat consensus estimates 11 times.
Actual EPS TrendRecently15Term · Feb 8, 2023 → Jul 22, 2026
Feb 8, 2023Range: -2.75 ~ 6.08Jul 22, 2026
Earnings History
| Date | Fiscal Period | EPS Est. | EPS Actual | Revenue Est. | Revenue Actual |
|---|---|---|---|---|---|
| Jul 22, 2026 | -- | 1.39 | 1.51 | $10.83B | $10.87B |
| Apr 22, 2026 | -- | 1.90 | Above forecast↑2.35 | $10.87B | $10.8B |
| Feb 5, 2026 | -- | 0.43 | Below forecast↓-2.75 | $10.88B | $11.38B |
| Oct 22, 2025 | -- | 3.97 | Below forecast↓1.84 | $11.29B | $11.48B |
| Jul 23, 2025 | -- | 5.62 | 5.48 | $10.95B | $11.43B |
| Apr 23, 2025 | -- | 5.97 | 6.08 | $10.84B | $11.15B |
| Feb 5, 2025 | -- | 5.74 | 5.05 | $10.28B | $10.5B |
| Oct 23, 2024 | -- | 5.81 | 6.01 | $9.91B | $10.34B |
| Jul 24, 2024 | -- | 5.50 | 5.86 | $9.75B | $9.86B |
| Apr 24, 2024 | -- | 5.59 | 5.73 | $9.45B | $9.93B |
| Feb 7, 2024 | -- | 4.35 | 4.38 | $8.37B | $9.05B |
| Oct 25, 2023 | -- | 4.88 | 5.05 | $8.24B | $8.55B |
| Jul 26, 2023 | -- | 5.10 | 5.65 | $8.25B | $8.33B |
| Apr 26, 2023 | -- | 5.12 | 5.81 | $8.33B | $8.15B |
| Feb 8, 2023 | -- | 4.06 | 4.10 | $7.87B | $8.22B |
Original Filings (SEC)
10-Q2026-07-23 ↗
8-K2026-07-22 ↗
8-K2026-06-10 ↗
8-K2026-05-11 ↗
8-K2026-05-08 ↗
10-Q2026-04-23 ↗
8-K2026-04-22 ↗
8-K2026-02-26 ↗
Links point to the company's original filings on the U.S. Securities and Exchange Commission (SEC) website.
Report dates are US trading days (Eastern Time); EPS and revenue estimates are market consensus, in USD. This page is for reference only and does not constitute investment advice.
